Literature DB >> 23083368

Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection.

Colin J Davidson1, Emily Zeringer, Kristen J Champion, Marie-Pierre Gauthier, Fawn Wang, Jerry Boonyaratanakornkit, Julie R Jones, Edgar Schreiber.   

Abstract

Fluorescent dye terminator Sanger sequencing (FTSS), with detection by automated capillary electrophoresis (CE), has long been regarded as the gold standard for variant detection. However, software analysis and base-calling algorithms used to detect mutations were largely optimized for resequencing applications in which different alleles were expected as heterozygous mixtures of 50%. Increasingly, the requirements for variant detection are an analytic sensitivity for minor alleles of <20%, in particular, when assessing the mutational status of heterogeneous tumor samples. Here, we describe a simple modification to the FTSS workflow that improves the limit of detection of cell-line gDNA mixtures from 50%-20% to 5% for G>A transitions and from 50%-5% to 5% for G>C and G>T transversions. In addition, we use two different sample types to compare the limit of detection of sequence variants in codons 12 and 13 of the KRAS gene between Sanger sequencing and other methodologies including shifted termination assay (STA) detection, single-base extension (SBE), pyrosequencing (PS), high- resolution melt (HRM), and real-time PCR (qPCR).

Entities:  

Year:  2012        PMID: 23083368     DOI: 10.2144/000113913

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  6 in total

1.  High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.

Authors:  Kiyotaka Saito; Kiyotaka Yokogami; Kazunari Maekawa; Yuichiro Sato; Shinji Yamashita; Fumitaka Matsumoto; Asako Mizuguchi; Hideo Takeshima
Journal:  Hum Cell       Date:  2021-01-17       Impact factor: 4.174

2.  Development of a gLCR-based KRAS mutation detection approach and its comparison with other screening methods.

Authors:  Stefan Jenner; Dieter Techel
Journal:  Tumour Biol       Date:  2015-03-27

3.  A novel nonsense mutation in ARMC5 causes primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Wen-Tao He; Xiong Wang; Wen Song; Xiao-Dong Song; Yan-Jun Lu; Yan-Kai Lv; Ting He; Xue-Feng Yu; Shu-Hong Hu
Journal:  BMC Med Genomics       Date:  2021-05-10       Impact factor: 3.063

4.  A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis.

Authors:  Olus Uyar; Pier-Luc Plante; Jocelyne Piret; Marie-Christine Venable; Julie Carbonneau; Jacques Corbeil; Guy Boivin
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

5.  Unusual mtDNA Control Region Length Heteroplasmy in the COS-7 Cell Line.

Authors:  Nataliya Kozhukhar; Sunil Mitta; Mikhail F Alexeyev
Journal:  Genes (Basel)       Date:  2020-05-30       Impact factor: 4.096

Review 6.  Cytogenetic and molecular diagnostic testing associated with prenatal and postnatal birth defects.

Authors:  Stela Z Berisha; Shashi Shetty; Thomas W Prior; Anna L Mitchell
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.